- Home
- / Ablacon
Ablacon
Total Funding
$33.5 M
Ablacon Summary
Company Summary
- Overview
- Ablacon is an AI-based provider of atrial fibrillation therapy. It offers cardiology, computer vision, neural networks, electrophysiology, arrhythmia, diagnosis, and other services.
- Type
- Private
- Status
- Active
- Founded
- 2015
- HQ
- Wheat Ridge, CO, US | view all locations
- Website
- http://ablacon.com/
- Cybersecurity rating
Table of Contents
Key People
Josef Koblish, President & COO
Melissa H. Kong, Chief Clinical Officer
Peter Ruppersberg, Founder & CSO
LocationsView all
3 locations detected
Wheat Ridge, CO HQ
United States
4800 Wadsworth Blvd #310
Munich, BY
Germany
Walter-Gropius-Straße 17
Blonay, VD
Switzerland
Chem. du Signal 53